Drug Improves Sight in Diabetic Retinopathy

Drug Improves Sight in Diabetic Retinopathy

 

Action Points

• This study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
• Intravitreal ranibizumab, currently approved for wet age-related macular degeneration, retinal vein occlusion, and diabetic macular edema, appears to prevent further worsening of diabetic retinopathy and actually improves the condition in some patients, a study found.